Fingerprint
Dive into the research topics of 'Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically